Lysyl Oxidase Inhibition by Heparin in Idiopathic Pulmonary Fibrosis: Is There Still Hope?

2017 ◽  
Vol 195 (1) ◽  
pp. 141-142 ◽  
Author(s):  
Rob Janssen
2013 ◽  
Vol 43 (5) ◽  
pp. 1430-1438 ◽  
Author(s):  
J. W. Chien ◽  
T. J. Richards ◽  
K. F. Gibson ◽  
Y. Zhang ◽  
K. O. Lindell ◽  
...  

Thorax ◽  
2021 ◽  
pp. thoraxjnl-2020-215745 ◽  
Author(s):  
Ying Wei ◽  
Wenting Dong ◽  
Julia Jackson ◽  
Tsung-Che Ho ◽  
Claude Jourdan Le Saux ◽  
...  

We recently identified epigallocatechin gallate (EGCG), a trihydroxyphenolic compound, as a dual inhibitor of lysyl oxidase-like2 and transforming growth factor-β1 (TGFβ1) receptor kinase that when given orally to patients with idiopathic pulmonary fibrosis (IPF) reversed profibrotic biomarkers in their diagnostic biopsies. Here, we extend these findings to advanced pulmonary fibrosis using cultured precision-cut lung slices from explants of patients with IPF undergoing transplantation. During these experiments, we were surprised to discover that not only did EGCG attenuate TGFβ1 signalling and new collagen accumulation but also activated matrix metalloproteinase-dependent collagen I turnover, raising the possibility of slow fibrosis resolution with continued treatment.


Thorax ◽  
2012 ◽  
Vol 67 (Suppl 2) ◽  
pp. A111.2-A111 ◽  
Author(s):  
CJ Calderwood ◽  
MG Jones ◽  
L Hoile ◽  
T Havelock ◽  
TM Maher ◽  
...  

Pneumologie ◽  
2011 ◽  
Vol 65 (12) ◽  
Author(s):  
S Barkha ◽  
M Gegg ◽  
H Lickert ◽  
M Königshoff

Pneumologie ◽  
2012 ◽  
Vol 66 (06) ◽  
Author(s):  
P Mahavadi ◽  
S Ahuja ◽  
I Henneke ◽  
W Klepetko ◽  
C Ruppert ◽  
...  

Pneumologie ◽  
2014 ◽  
Vol 68 (06) ◽  
Author(s):  
S Skwarna ◽  
I Henneke ◽  
W Seeger ◽  
T Geiser ◽  
A Günther ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document